Literature DB >> 35307584

Skin sympathetic nerve activity in patients with chronic orthostatic intolerance.

Andrew Lee1, Xiao Liu1, Carine Rosenberg1, Sanjana Borle1, Daerin Hwang1, Lan S Chen1, Xiaochun Li2, Noel Bairey Merz3, Peng-Sheng Chen4.   

Abstract

BACKGROUND: Chronic orthostatic intolerance (OI) is characterized by the development of tachycardia and other symptoms when assuming an upright body position.
OBJECTIVE: The purpose of this study was to test the hypothesis that skin sympathetic nerve activity (SKNA) bursts are specific symptomatic biomarkers in patients with chronic OI.
METHODS: We used an electrocardiogram monitor with a built-in triaxial accelerometer to simultaneously record SKNA and posture in ambulatory participants. Study 1 compared chronic OI (14 women and 2 men; mean age 35 ± 10 years) with reference control participants (14 women; mean age 31 ± 6 years). Study 2 included 17 participants with chronic OI (15 women and 2 men; mean age 39 ± 12 years) not yet treated with ivabradine, pyridostigmine, or β-blockers.
RESULTS: In study 1, there were 124 episodes (8 ± 4 per participant) of postural changes, with 11 episodes (8.9%) associated with symptoms. In comparison, 0 of 104 postural changes (7 ± 3 per participant) in controls were symptomatic (P = .0011). In participants with chronic OI, the SKNA bursts associated with symptoms had higher burst frequencies, longer burst durations, and larger mean burst areas than did bursts during asymptomatic periods. However, SKNA bursts and tachycardia were asymptomatic in controls. We analyzed 110 symptomatic episodes in study 2 (6 ± 5 per participant). Among them, 98 (89.1%) followed at least 1 SKNA burst. In comparison, only 41 (37.3%) had heart rate exceed 100 beats/min 1 minute before symptom onset (P < .0001).
CONCLUSION: SKNA bursts are a highly specific, albeit insensitive, symptomatic biomarker for chronic OI.
Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Active standing test; Ambulatory ECG monitor; Interoception; Postural orthostatic tachycardia syndrome; Postural symptoms without tachycardia; Sympathetic nerve activity

Mesh:

Year:  2022        PMID: 35307584      PMCID: PMC9250599          DOI: 10.1016/j.hrthm.2022.03.015

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.779


  25 in total

Review 1.  The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS).

Authors:  Alison Kohn; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2020-06       Impact factor: 8.667

2.  Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control.

Authors:  R Furlan; G Jacob; M Snell; D Robertson; A Porta; P Harris; R Mosqueda-Garcia
Journal:  Circulation       Date:  1998-11-17       Impact factor: 29.690

3.  The genesis and presentation of anxiety in disorders of autonomic overexcitation.

Authors:  Andrew P Owens; David A Low; Valeria Iodice; Hugo D Critchley; Christopher J Mathias
Journal:  Auton Neurosci       Date:  2016-10-19       Impact factor: 3.145

4.  Simultaneous noninvasive recording of skin sympathetic nerve activity and electrocardiogram.

Authors:  Anisiia Doytchinova; Jonathan L Hassel; Yuan Yuan; Hongbo Lin; Dechun Yin; David Adams; Susan Straka; Keith Wright; Kimberly Smith; David Wagner; Changyu Shen; Vicenta Salanova; Chad Meshberger; Lan S Chen; John C Kincaid; Arthur C Coffey; Gang Wu; Yan Li; Richard J Kovacs; Thomas H Everett; Ronald Victor; Yong-Mei Cha; Shien-Fong Lin; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2016-09-23       Impact factor: 6.343

5.  Validity of using tri-axial accelerometers to measure human movement - Part I: Posture and movement detection.

Authors:  Vipul Lugade; Emma Fortune; Melissa Morrow; Kenton Kaufman
Journal:  Med Eng Phys       Date:  2013-07-27       Impact factor: 2.242

6.  Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance.

Authors:  Satish R Raj; Juan C Guzman; Paula Harvey; Lawrence Richer; Ronald Schondorf; Colette Seifer; Nicolas Thibodeau-Jarry; Robert S Sheldon
Journal:  Can J Cardiol       Date:  2020-03       Impact factor: 5.223

7.  Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association.

Authors:  Ritsuko Kohno; David S Cannom; Brian Olshansky; Shijun Cindy Xi; Darshan Krishnappa; Wayne O Adkisson; Faye L Norby; Artur Fedorowski; David G Benditt
Journal:  J Am Heart Assoc       Date:  2021-08-16       Impact factor: 5.501

Review 8.  Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?

Authors:  Svetlana Blitshteyn
Journal:  J Neurol       Date:  2021-03-07       Impact factor: 4.849

9.  Mental Stress Elicits Sustained and Reproducible Increases in Skin Sympathetic Nerve Activity.

Authors:  Matthew D Muller; Charity L Sauder; Chester A Ray
Journal:  Physiol Rep       Date:  2013-03

10.  Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2.

Authors:  Satish R Raj; Kate M Bourne; Lauren E Stiles; Mitchell G Miglis; Melissa M Cortez; Amanda J Miller; Roy Freeman; Italo Biaggioni; Peter C Rowe; Robert S Sheldon; Cyndya A Shibao; Andre Diedrich; David M Systrom; Glen A Cook; Taylor A Doherty; Hasan I Abdallah; Blair P Grubb; Artur Fedorowski; Julian M Stewart; Amy C Arnold; Laura A Pace; Jonas Axelsson; Jeffrey R Boris; Jeffrey P Moak; Brent P Goodman; Kamal R Chémali; Tae H Chung; David S Goldstein; Anil Darbari; Steven Vernino
Journal:  Auton Neurosci       Date:  2021-06-30       Impact factor: 2.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.